MedTrace Logo

Exploring the Effectiveness of AI Generative Models for Diabetic Patients

NCT05883072 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2023-06-05

No results posted yet for this study

Summary

We plan to explore the usability of Generative AI-Chatbot for Diabetic Patient

Conditions

Interventions

BEHAVIORAL

Exploring AI-Chatbot

All participants will be provided access to AI-Chatbot and will be asked to enquire their daily life problems related to diabetes. They will also be asked to review the replies of the Chatbot after their interaction.

Sponsors & Collaborators

  • Pakistan Council of Scientific and Industrial Research

    lead OTHER

Principal Investigators

  • Ghulam Mustafa · Pakistan Council of Scientific and Industrial Research

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-01-05
Primary Completion
2024-12-30
Completion
2026-12-31

Countries

  • Pakistan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05883072 on ClinicalTrials.gov